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Objective: This study compared human primary osteoblasts derived from hip osteoarthritis (OA) cases
against controls (CTLs) to investigate candidate OA disease genes, twist homologue 1 (TWIST1), wingless
MMTV integration site family member 5B (WNT5B), transforming growth factor-b (TGFb1) and SMAD
family member 3 (SMAD3), during osteoblast differentiation, relative to calcium apposition and
elemental mineral composition.
Materials & methods: Primary osteoblast cultures were generated from intertrochanteric trabecular bone
samples from ﬁve female primary hip OA cases and ﬁve age-matched female CTLs. During a 42-day
differentiation time-course, alizarin red stains, energy-dispersive X-ray spectroscopy and real-time RT-
polymerase chain reaction (PCR) were used to quantify calcium, elemental composition and gene
expression, respectively. Data were analysed using linear mixed effects models and Pearson correlation
matrices.
Results: Signiﬁcant differences, correlations and associations were found in OA and CTL osteoblasts
between gene and mineral measures. The calcium: phosphorous (Ca:P) ratio was signiﬁcantly more
varied in OA compared to CTL. Calcium apposition, mineral composition as well as TWIST1 and TGFb1
mRNA expression changed signiﬁcantly over time. TWIST1 mRNA expression was elevated and correlated
with SMAD3 mRNA levels in the OA cohort during the time-course. Associations were observed between
tissue non-speciﬁc alkaline phosphatase (TNAP), osteocalcin (OCN), TWIST1, TGFb1, SMAD3 mRNA levels
and mineral measures in OA against CTL. Temporal differences between SMAD3 mRNA expression and
mineral composition were also found in OA.
Conclusions: Dysregulated expression of TWIST1, TGFb1 and SMAD3 mRNA observed in OA bone is re-
ﬂected in the functionality of the osteoblast when these cells are cultured ex vivo. The results presented
here are consistent with at least part of the aetiology of primary hip OA deriving from altered intrinsic
properties of the osteoblast.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Primary osteoarthritis (OA) commonly occurs in the hip joint1.
The pathophysiology of hip OA involves the whole joint with focal
and progressive hyaline articular cartilage loss and concomitant
changes in the subchondral bone, including development of
marginal bone outgrowths, osteophytes, and increased thickness of
the bony envelope2.o: G.J. Atkins, Discipline of
de, North Terrace, Adelaide,
Fax: 61-8-8232-3065.
. Atkins).
s Research Society International. PThe processes underlying joint degeneration in OA remains
poorly understood1 but has been attributed to intrinsic abnor-
malities in the joint tissue and the subsequent response to
mechanical loading3. Several studies have revealed concomitant
changes in both the cartilage and bone, and early changes in OA
may even initiate in the bone3e6. Genetic factors explain at least
60% of the susceptibility to primary hip OA7. Linkage and associa-
tion studies have identiﬁed genetic candidates from the wingless
MMTV integration (WNT) and transforming growth factor-b (TGFb)
signalling pathways6,7. Variations in WNT and TGFb pathway gene
expression were identiﬁed in OA intertrochanteric (IT) trabecular
bone, including twist homologue 1 (TWIST1), Wnt integration site
family member 5B (WNT5B), TGFb1 and SMAD family member 3ublished by Elsevier Ltd. All rights reserved.
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identiﬁed in iliac crest bone9. Femoral trabecular bone from hip OA
cases displayed altered material properties and composition10.
Furthermore, correlations have been observed in OA bone between
differentially expressed molecules of the WNT and TGFb pathways,
as well as correlations between gene expression and altered his-
tomorphometric indices11. Together, these studies suggest that at
least a component of OA aetiology resides in the bone and is
attributable to an altered state of osteoblast differentiation and
function, driven by differential expression of critical molecular
regulators11.
The aim of the current study was to test the hypothesis that the
expression of the candidate OA disease genes TWIST1, WNT5B,
TGFb1 and SMAD3 is related to measures of osteoblast differenti-
ation. Osteoblasts cultured from IT trabecular bone explants of
female primary hip OA or control (CTL) patients were examined
over an extended differentiation time-course (42 days) under
conditions permissive for differentiation and mineralisation
in vitro. Calcium apposition, mineral composition and gene
expressionwere quantiﬁed and analysed using linear mixed effects
models (LMEMs) to identify interrelationships between these
measures.
Methods
Bone samples
Trabecular bone samples from the IT region of the proximal
femur were obtained from ﬁve female hip OA patients (mean
age¼ 67 12 years) requiring total hip replacement surgery. These
were macroscopically graded as either Grade III or IV, by assess-
ment of the degree of ﬁbrillation and degeneration11,12. The CTL
cohort comprised ﬁve female non-OA neck of femur fracture cases
(mean age ¼ 81  6 years) who were free of any medication
affecting bone metabolism and of any extenuating bone patho-
logy13e18. No signiﬁcant difference in age was found between OA
and CTL cohorts (Student’s t-test, P > 0.05). The trabecular bone
samples were obtained as cylindrical tube saw biopsies approxi-
mately 50 mm in length and 10 mm in diameter. Informed consent
was obtained for the collection of these specimens, with approval
from the Royal Adelaide Hospital Human Research Ethics
Committee.
Primary OA and CTL osteoblast cultures
Primary osteoblasts were cultured from bone chips as previ-
ously described19. Brieﬂy, samples were rinsed 10 times in
phosphate-buffered saline (PBS), diced and cultured in a-MEM
(Flow Laboratories, Irvine, Scotland), containing 10% foetal calf
serum (FCS, Thermotrace, Noble Park, VIC, Australia), media addi-
tives and 100 mM L-ascorbate-2-phosphate (Novachem, Melbourne,
VIC, Australia)19. At conﬂuence cells were passaged by collagenase/
dispase digestion19. To obtain sufﬁcient cell numbers from all
donors, it was necessary to expand all cultures by passage for
experimentation a further three times. Assessment of gene
expression of non-passaged cells under normal growth conditions
compared with those used for experimentation conﬁrmed a similar
level of expression of the genes of interest and no disease-speciﬁc
changes (Table SI), consistent with our previous published20e22
and unpublished ﬁndings that these cells retain a stable pheno-
type over a similar passage range. For experimentation, fourth
passage cells from each donor were seeded at 6  105 cells/ﬂask
into 25-cm2 tissue culture ﬂasks for gene expression analysis.
Concurrently, cells were seeded (1.2  104 cells/well) into eight-
well Permanox Chamber Slides (Nunc, Rochester, NY, USA) foralizarin stains and energy-dispersive X-ray spectroscopy (EDS)
analysis. After 24 h and every 3 days thereafter, media were
replaced with the addition of 10 nM dexamethasone (Fauldings,
Adelaide, SA, Australia) and 1.8 mM KH2PO419,22e24.
Calcium apposition
At the indicated time points, for the analysis of calcium appo-
sition, media were removed and the cells rinsed with PBS (200 mL,
5 min). The cells were then ﬁxed with formalin (10% w/v, 1 h at
room temperature), followed by three rinses with distilled water
(dH2O). Wells were then stained with alizarin red (1%, w/v in 2%
ethanol, 0.2 mL/well) for 5 min at room temperature and rinsed
with dH2O ﬁve times. After imaging (Olympus SZX10, Centre Valley,
PA, USA), staining was quantiﬁed solubilising the stain in 10% acetic
acid with agitation for 30 min. Digests were then transferred to
a 1.5 ml reaction tube, agitated for 30 s, heated to 85C and cooled
on ice for 5 min. The mixture was then centrifuged at 20,000g for
15 min and the supernatant transferred to a fresh tube. The pH was
then neutralised using 60 mL 10% NH4OH (pH 4.1e4.5). A 150 mL
sample was transferred to a 96-well plate and optical density
measured at 405 nm.
EDS microanalysis of mineral composition
Mineral composition analysis was performed as described22, but
with some modiﬁcations. Media were removed and cells washed
with 200 mL of dH2O for 5 min at room temperature. Cells were
ﬁxed with 200 mL of 2.5% gluteraldehyde for 2 h at room temper-
ature. Samples were then dehydrated with an increasing ethanol
concentration series (70%, 90%, 100%) of 200 mL for 5 min each, air-
dried, carbon coated (Denton Vacuum DV-502, Moorestown, NJ,
USA), and examined on an electron microscope (XL30, Philips,
USA). Elemental composition was assessed using EDS analytical
software (EDAX Genesis Spectrum, Mahwah, NJ, USA), with an
accelerating voltage of 10 kV and a working distance of 10 mm. The
microprobe was calibrated with a take-off angle of 38 and an
acquisition time of 50 s. The relative weight of calcium (rWt %Ca),
phosphorus (rWt %P) and carbon (rWt %C) were quantiﬁedwith the
correction of atomic number, absorption, and ﬂuorescence effects
for each analysis25e27. As the slides were carbon coated, the
element of C was held to be consistently in excess and a reliable CTL
element for the individual comparison of the elements under study.
The ratios of calcium: phosphorous (Ca:P) (rWt %Ca/rWt %P ¼ RCa/
P), Ca:C (rWt %Ca/rWt %C¼ RCa/C) and P:C (rWt %P/rWt %C¼ RP/C)
were then determined.
RNA and real-time polymerase chain reaction (PCR)
Total RNA was extracted and complementary DNA (cDNA)
prepared, as described19. Oligonucleotide primers speciﬁc for
mRNA were designed in-house for the real-time RT-PCR ampliﬁ-
cation of tissue non-speciﬁc alkaline phosphatase (TNAP), osteo-
calcin (OCN), TWIST1, WNT5B, TGFb1, SMAD3 and GAPDH
(Table SII)19. All PCR reactions were validated bymelt curve analysis
and agarose gel electrophoresis. Relative expression between
samples was calculated using the comparative cycle threshold (CT)
method (DCT)19,28.
Data analysis
Ca apposition, mineral composition and normalised gene
expression levels were analysed using LMEMs (SAS Version 9.2, SAS
Institute Inc., Cary, NC, USA) and Pearson correlation matrices
(Graphpad Prism v5.04 San Diego, CA, USA)29. The ﬁrst aim of this
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above measures between OA and CTL. For each measure, an LMEM
with group, time and the interaction between group and time was
ﬁtted to the data. A random patient effect was ﬁtted to themodel to
allow for the dependence between repeated observations on the
same donor’s cells. Two LMEMs were compared; one where the
variance in the outcome was assumed to be the same in both
cohorts and another, where the variances were allowed to differ.
The ﬁt of the two LMEMs was compared using a likelihood-ratio
test, with a signiﬁcant test indicative of a difference in variance
between the cohorts. Differences in mean values between cohorts
over time were then interpreted using the LMEM with the more
appropriate variance structure. In the presence of a statistically
signiﬁcant interaction between group and time, differences in each
respective measure between cohorts were assessed at each time
point. If no signiﬁcant interactionwas observed another LMEMwas
ﬁtted to assess differences in each measure between groups
regardless of time or alternatively over time regardless of group. Of
the measures found to have signiﬁcant differences over time
regardless of group, indicative of general features of human oste-
oblast differentiation, further analyses of speciﬁc differences
between individual time points were also conducted using post-hoc
tests.
The second aim was to identify relationships between the
expression of the various genes examined at individual time points
for each of the OA and CTL cohorts. Pearson product moment (r)
matrices speciﬁc to each time point within each cohort were
applied to examine correlations between genes.
The third aim was to identify whether the observed gene
expression patterns and their relationships to mineral measures
were different between OA and CTL groups, and whether these
differences were dependent on time. For each gene expression and
mineral measure, LMEMs were ﬁtted to the data including all two-
and three-way interactions between group, time and mineral. Non-
signiﬁcant interaction effects were then removed from the LMEM
sequentially to arrive at a ﬁnal model. Where a signiﬁcant three-
way interaction was observed, the association between gene
expression and mineral measure was quantiﬁed separately for each
time point and group. In the absence of a three-way interaction,
associations were quantiﬁed for both groups independently of time
and over time regardless of group. TNAP and OCN could not be
analysed as these measures did not satisfy the assumptions of the
LMEM. The value for signiﬁcance chosen throughout was two-
tailed P < 0.05.
Results
In this study, primary osteoblasts from ﬁve OA and ﬁve CTL cases
were grown under conditions permissive for human osteoblast
differentiation and in vitro mineralisation, over a period of
42 days19e22. These examinations were conducted in order to
detect altered expression of candidate OA disease genes (TWIST1,
WNT5B, TGFb1 and SMAD3) and the relationships of these to
osteoblast differentiation genes TNAP and OCN, calcium apposition
and mineral composition in differentiating hip OA osteoblasts.
LMEMs and Pearson correlation matrices were then applied to
analyse each of these measures and the interactions between them.
Mineralisation measures and gene expression levels in OA
osteoblasts
OA and CTL osteoblasts mineralised in vitro to a similar extent
[Fig. 1(AeC)]. However, while the Ca:P ratio in CTL cultures always
attained the expected value of w1.630, the ratio in OA cultures
appeared more varied [Fig. 1(D)]. LMEM analysis conﬁrmed thatamong the mineral measures, only the Ca:P ratio was signiﬁcantly
more varied in the OA group compared to the CTL (Table I).
Assessment of ﬁxed effects revealed that Ca apposition was only
different over time regardless of group (Fig. 1; Table II). The three
mineral composition ratios Ca:P, Ca:C and P:C were signiﬁcantly
different over time regardless of group, consistent with the matu-
ration of mineral crystals during osteoblast differentiation. Signif-
icant differences over time regardless of group were further
analysed, as described below.
Cells from both cohorts expressed all of the genes examined in
this study, albeit to varying extents (Fig. 2). The statistical variance
in expression for all of the candidate OA disease genes tested was
not different between groups (Table I). Differences in relative gene
expression between cohorts and with respect to time, however,
were observed. The relative expression of TWIST1 mRNA was not
different between the two groups with respect to time, however
was signiﬁcantly higher in the OA group compared to the CTL
overall, regardless of time, and also signiﬁcantly different over time
regardless of group (Table II). While TGFb1 mRNA expression was
not signiﬁcantly different between groups over time, the difference
between groups independently of time reached borderline signif-
icance (P ¼ 0.05) reﬂected in the distinct expression pattern ob-
tained for this gene [Fig. 2(IeJ)]. TGFb1 mRNA was also
differentially expressed over time regardless of group.
Temporal patterns of mineralisation independent of group
The temporal changes among the mineral parameters and gene
expression were also examined. For measures different over time
regardless of group, further analysis using LMEMs was conducted
to identify signiﬁcant differences at speciﬁc time points (Table III).
As expected, Ca apposition was lower at day 7 than all later time
points and increased from day 14 to days 21, 28, 35 and 42 (Fig. 1).
Ca:P ratios were consistently higher at days 14, 21, 28 and 35 than
at day 42. Ca:C ratios were signiﬁcantly lower at day 7 compared to
days 14, 21, 28, 35 and 42. P:C ratios were signiﬁcantly lower at days
7 and day 14, compared to later time points.
Temporal patterns of gene expression independent of group
As shown in Table III, irrespective of group, relative TWIST1
mRNA expression increased over time with signiﬁcant differences
between most time points examined. TGFb1 mRNA expression was
signiﬁcantly lower at day 14 compared to day 21, but higher at days
21 and 28 compared to days 35 and 42 respectively.
Group speciﬁc correlations in gene expression
In order to identify differences between OA and CTL osteoblasts
in terms of their patterns of gene expression during differentiation,
correlations between the expression of gene pairs were examined.
This analysis revealed a complex interplay between genes, often
only at speciﬁc time points during the differentiation time-course
(Table IV). TWIST1 and TNAP mRNA expression correlated posi-
tively at days 7, 35 and 42 in OA. TWIST1 mRNA expression also
correlated positively with SMAD3 throughout the time-course and
overall, exclusively in OA. Further OA-speciﬁc relationships
included WNT5B mRNA expression and TGFb1 correlating posi-
tively at days 28e42, and overall. TWIST1 and SMAD3 mRNA
expression correlated with that of OCN positively in OA at day 35.
SMAD3 expression correlated with OCN and also with TNAP in
OA at day 42.
TNAP and OCN mRNA expression, two genes associated with
osteoblast differentiation22,31, correlated positively at day 7 in CTLs.
Further CTL-speciﬁc gene correlations included TGFb1 with SMAD3
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Fig. 1. (A) Alizarin red stains from primary osteoblast cultures differentiated over 42 days generated from the IT trabecular bone of a female hip OA case and a CTL. (B) Calcium
apposition generated from quantiﬁed alizarin red stains from primary osteoblast cultures differentiated over 42 days generated from the IT trabecular bone of age and sex-matched
female hip OA and CTL cases, values are means  standard error of the mean (S.E.M.) of quadruplicate stains. (C) Images produced by scanning electron microscopy at 2000
magniﬁcation from primary osteoblast cultures differentiated over 42 days generated from the IT trabecular bone of a female hip OA case and a CTL. (D) Ca:P ratios assessed using
energy-dispersive x-ray microanalysis from primary osteoblast cultures differentiated over 42 days generated from the IT trabecular bone of age and sex-matched female hip OA
and CTL cases, values are means  S.E.M. of quadruplicate scans.
Table I
Comparison of variance in calcium apposition, mineral composition and normalised
gene expression from primary osteoblast cultures between OA and CTL cases over
a 42-day time-course*
Chi-squared (c2) Degrees of
freedom (DF)
P-value
Calcium apposition (alizarin red)
Ca 4.97 2 0.08
Mineral composition (EDS)
Ca:P 27.33 2 <0.01
Ca:C 5.20 2 0.07
P:C 0.29 2 0.87
Gene
TWIST1 2.78 2 0.25
WNT5B 0.83 2 0.66
TGFb1 5.37 2 0.07
SMAD3 1.11 2 0.58
* Differences in variance were assessed using two LMEMs of equal and unequal
variance followed by a likelihood-ratio test.
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expression correlated positively with OCN in CTLs. TGFb1 and TNAP
mRNA expression also correlated positively overall in the CTL
cohort.
Relationships between gene pairs common to both OA and CTL
were rare but included TNAP with both TWIST1 and TGFb1, and
WNT5B with TGFb1 and OCN, across the time-course (Table IV).
Associations between gene expression and mineral measures
Associations between OA and CTL gene expression and
mineral measures were examined next using LMEMs. Included in
this analysis were associations between gene expression and
mineral measures independent of group. The F-values and cor-
responding P-values are presented in Table V. The association
between TNAP expression and Ca:P was not different between
Table II
Comparison of ﬁxed effects in calcium apposition, mineral composition and nor-
malised gene expression from primary osteoblast cultures between OA and non-OA
CTL cases over a 42-day time-course*
Fixed effects F-value P-value
Calcium apposition (alizarin red)
Ca Group & time 0.68 0.64
Group 0.39 0.55
Time 7.40 <0.01
Mineral composition (EDS)
Ca:P Group & time 0.90 0.49
Group 4.45 0.07
Time 2.94 0.02
Ca:C Group & time 0.77 0.58
Group 4.05 0.08
Time 3.46 0.01
P:C Group & time 0.78 0.57
Group 1.42 0.27
Time 3.88 0.01
Gene
TWIST1 Group & time 0.97 0.45
Group 7.56 0.03
Time 2.79 0.03
WNT5B Group & time 0.25 0.94
Group 2.21 0.18
Time 1.95 0.10
TGFb1 Group & time 1.73 0.15
Group 5.25 0.05
Time 2.58 0.04
SMAD3 Group & time 1.40 0.25
Group 0.48 0.51
Time 1.20 0.33
* Signiﬁcant differences in interaction for each measure across the two groups
over time, as well as group independent of time and over time independent of group
were assessed using LMEM analysis.
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between groups independently of time and also over time
independently of group. Interestingly, in the OA group, TNAP was
negatively associated with Ca:P, while in the CTL cohort it was
positively associated.
The associations between OCN expression and mineral compo-
sition ratios Ca:P and Ca:C were signiﬁcantly different between
groups regardless of time. These was a trend towards signiﬁcance
for the association between OCN and Ca:P over time independently
of group. Similar to the ﬁndings for TNAP, in the OA group OCN was
negatively associated with both Ca:P and Ca:C respectively, while in
the CTL it was positively associated.
For TWIST1, there were few differences between the various
associations, with respect to OA and CTL or time. However, there
was a difference between the two groups in the association of
TWIST1 and Ca:C independently of time. In the OA group, TWIST1
was negatively associated with Ca:C, while in the CTL it was posi-
tively associated. The association between TGFb1 and P:C was
different over time independent of group. The association between
SMAD3 mRNA expression and the Ca:P ratio was however different
over time independent of group. Interestingly, both the associations
between SMAD3 mRNA levels and the composition ratios Ca:C and
P:C differed between groups over time.
Comparisons of gene and mineral associations between groups
against zero
Among those associations different between the cell cohorts
independently of time, further LMEM analysis was conducted to
identify differences between each association against zero (no
association at all). As seen in Table VI, the association between
TNAP mRNA expression and the Ca:P ratio in CTL was different
against zero. The associations between OCN mRNA expressionand Ca:P and Ca:C, respectively, were different in OA compared to
zero. The associations between TWIST1 mRNA expression and the
Ca:C ratios in both cohorts were also different against zero
(Table VI).
Temporal changes in the relationships between gene expression and
mineral measures
For those associations signiﬁcantly different between the two
groups over time, or over time regardless of group, further
LMEM analysis was conducted to identify differences at speciﬁc
time points against zero (Table VII). Group-independent associ-
ations over time between TNAP and Ca:P, TGFb1 and P:C, SMAD3
expression and Ca:P, respectively, were different against zero at
single time points. The association between SMAD3 and Ca:C
was signiﬁcantly different to zero in the OA cohort at days 7, 28,
35 and 42. In the CTL cohort, a signiﬁcant difference to zero
between SMAD3 and Ca:C was observed only at day 42. Finally,
the association between SMAD3 expression and the P:C ratio
was signiﬁcantly different from zero at day 35, only in the OA
cohort.
Discussion
In this study, candidate OA disease genes, TGFb1, SMAD3,
WNT5B and TWIST1, previously identiﬁed in whole bone
extracts8,11, were examined at the level of the osteoblast, to
determine if they inﬂuence osteoblast behaviour in terms of
gene expression, mineralisation and mineral composition over
an extended time-course, and to examine the relationships
between these parameters.
Previous studies have shown systemic differences in hip OA
from the femoral head and neck with regard to the bony material
properties10,32,33 and differences in the inorganic fraction of the OA
bone was found in comparison to CTLs10. In this study, the ratios of
Ca:P, Ca:C and P:C were all signiﬁcantly different over time inde-
pendent of group, consistent with mineral maturation during
osteoblast differentiation. However, the Ca:P ratio was more varied
in OA compared to CTL, suggesting that deregulation of mineral
deposition by osteoblasts contributes to the altered material state,
such as hypomineralisation, observed in OA bone10. Our ﬁndings
from the IT region are consistent with previous studies examining
the bone from the femoral head, neck and subchondral regions,
indicative of altered cellular activity in the pathology10,32e35. Bony
measures are not necessarily comparable with ex vivo cultured
osteoblasts, although the Ca:P ratio derived from the CTL cohort is
consistent with that measured in bone, the theoretical value for
hydroxyapatite (w1.6)30,36 and similar to previous ﬁndings with
human primary osteoblasts22. The increased variance in the Ca:P
ratio in OA cultures observed here is consistent with altered min-
eralisation in OA bone30.
Examination of gene expression in terms of altered minerali-
sation, as well as interrelationships between genes, was also con-
ducted to reveal potentially key molecular players driving the
dysfunctional properties of the OA osteoblast11,13,37,38. From this
perspective, the association between TNAP mRNA expression and
the Ca:P ratio in OA was signiﬁcantly different to that in CTL irre-
spective of time. This critical enzyme is an early osteoblast differ-
entiation marker and functions to degrade the mineralisation
inhibitor, pyrophosphate39. The association betweenTNAP and Ca:P
was signiﬁcantly different from zero exclusively among the CTLs;
the absence of this relationship in OA is indicative of altered
regulation of mineral deposition and osteoblast differentiation in
the pathology11,13. OCN mRNA expression and its association with
both Ca:P and Ca:C ratios were also signiﬁcantly different in OA
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Fig. 2. mRNA expression from primary osteoblast cultures differentiated over 42 days generated from the IT trabecular bone of age and sex-matched female hip OA and CTL cases.
Values are means  S.E.M. of triplicate reactions and normalised to GAPDH (A) & (B) TNAP, (C) & (D) OCN, (E) & (F) TWIST1, (G) & (H) WNT5B, (I) & (J) TGFb1, (K) & (L) SMAD3.
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Table III
Speciﬁc analysis of day by day differences in calcium apposition, mineral compo-
sition and normalised gene expression from OA and CTL primary osteoblast cultures
over a 42-day time-course*
Fixed effects
over time (days)
Mean
difference
t-value P-value
Calcium apposition (alizarin red)
Ca 7e14 0.88 3.94 <0.01
7e21 1.53 5.07 <0.01
7e28 1.73 4.89 <0.01
7e35 1.93 4.96 <0.01
7e42 2.32 5.54 <0.01
14e21 0.65 2.90 0.01
14e28 0.85 2.80 0.01
14e35 1.05 2.99 <0.01
14e42 1.44 3.69 <0.01
21e42 0.79 2.24 0.03
Mineral composition (EDS)
Ca:P 14e42 þ0.41 þ2.29 0.03
21e42 þ0.39 þ2.33 0.02
28e42 þ0.50 þ3.33 <0.01
35e42 þ0.40 þ3.42 <0.01
Ca:C 7e14 1.16 3.63 <0.01
7e21 1.62 3.75 <0.01
7e28 1.68 3.34 <0.01
7e35 1.77 3.20 <0.01
7e42 1.60 2.71 0.01
P:C 7e14 0.67 2.88 0.01
7e21 1.12 3.81 <0.01
7e28 1.40 3.87 <0.01
7e35 1.52 3.82 <0.01
7e42 1.63 3.86 <0.01
14e21 0.51 2.22 0.03
14e28 0.73 2.34 0.02
14e35 0.84 2.33 0.02
14e42 0.96 2.42 0.02
Gene
TWIST1 7e14 0.43 2.31 0.03
7e28 0.82 2.78 0.01
21e28 0.39 2.09 0.04
28e35 þ0.40 þ2.18 0.03
TGFb1 14e21 0.23 2.07 0.04
21e35 þ0.45 þ2.95 0.01
21e42 þ0.50 þ2.75 0.01
28e35 þ0.27 þ2.46 0.02
28e42 þ0.32 þ2.12 0.04
* Signiﬁcant differences over time independent of group were assessed using
post-hoc tests following LMEM analysis. Only values with signiﬁcant differences are
presented.
Table IV
Linear correlations (r) in normalised gene expression speciﬁc to each day from OA
and non-OA CTL primary osteoblast cultures over a 42-day time-course*
OA CTL
Gene correlations: day 7
TNAP vs OCN r ¼ 0.02, P ¼ 0.98 r ¼ þ0.96, P ¼ 0.01
TWIST1 vs TNAP r ¼ þ0.93, P ¼ 0.03 r ¼ þ0.59, P ¼ 0.30
TWIST1 vs SMAD3 r ¼ þ0.92, P ¼ 0.03 r ¼ þ0.03, P ¼ 0.96
Gene correlations: day 14
TWIST1 vs SMAD3 r ¼ þ0.99, P < 0.01 r ¼ 0.19, P ¼ 0.76
Gene correlations: day 21
TWIST1 vs SMAD3 r ¼ þ0.94, P ¼ 0.02 r ¼ þ0.04, P ¼ 0.95
TGFb1 vs SMAD3 r ¼ 0.76, P ¼ 0.14 r ¼ þ0.95, P ¼ 0.02
Gene correlations: day 28
TWIST1 vs SMAD3 r ¼ þ0.93, P ¼ 0.02 r ¼ þ0.45, P ¼ 0.45
WNT5B vs TGFb1 r ¼ þ0.99, P < 0.01 r ¼ 0.15, P ¼ 0.81
TGFb1 vs TNAP r ¼ 0.37, P ¼ 0.54 r ¼ þ0.91, P ¼ 0.03
Gene correlations: day 35
TWIST1 vs TNAP r ¼ þ0.91, P ¼ 0.03 r ¼ þ0.68, P ¼ 0.21
TWIST1 vs OCN r ¼ þ0.92, P ¼ 0.03 r ¼ þ0.12, P ¼ 0.85
TWIST1 vs SMAD3 r ¼ þ0.96, P ¼ 0.01 r ¼ þ0.87, P ¼ 0.06
WNT5B vs OCN r ¼ 0.46, P ¼ 0.43 r ¼ þ0.95, P ¼ 0.01
WNT5B vs TGFb1 r ¼ þ0.96, P ¼ 0.01 r ¼ 0.46, P ¼ 0.43
SMAD3 vs OCN r ¼ þ0.99, P < 0.01 r ¼ 0.33, P ¼ 0.59
Gene correlations: day 42
TWIST1 vs TNAP r ¼ þ0.99, P < 0.01 r ¼ þ0.26, P ¼ 0.67
TWIST1 vs SMAD3 r ¼ þ0.95, P ¼ 0.02 r ¼ þ0.05, P ¼ 0.94
WNT5B vs TGFb1 r ¼ þ0.92, P ¼ 0.03 r ¼ 0.19, P ¼ 0.76
SMAD3 vs TNAP r ¼ þ0.95, P ¼ 0.01 r ¼ þ0.50, P ¼ 0.40
SMAD3 vs OCN r ¼ þ0.89, P ¼ 0.04 r ¼ 0.30, P ¼ 0.62
Gene correlations: overall
TWIST1 vs SMAD3 r ¼ þ0.97, P ¼ 0.01 r ¼ þ0.20, P ¼ 0.75
WNT5B vs TGFb1 r ¼ þ0.98, P < 0.01 r ¼ 0.13, P ¼ 0.84
TGFb1 vs TNAP r ¼ 0.08, P ¼ 0.90 r ¼ þ0.95, P ¼ 0.01
* Only correlations signiﬁcant in one or both cohorts are presented.
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different from zero.
TNAP and OCN expression are both associated with osteoblast
differentiation31, and the positive correlation between these in the
CTL cohort is consistent with this. However this relationship did not
exist in OA cells. It should be noted that while previous studies have
found differences in TNAP and OCN expression in OA osteoblasts
and bone, these were sampled from different skeletal sites or
patient cohorts and utilised semi-quantitative rather than quanti-
tative gene expression analysis8,11,18,40. The current study did
however identify differences in terms of the way, in which TNAP
and OCN associate with mineral measures in OA, as discussed
above.
TGFb1 was differentially expressed over time during osteoblast
differentiation regardless of cohort, consistent with its critical role
in the development of the mature mineralising osteoblast13,41.
Although its expression was not altered in OA osteoblasts, TGFb1
and WNT5B correlated positively throughout the latter (post-
proliferative) stages of the time-course and overall, uniquely in OA.Given the well established regulatory function of TGFb1 in osteo-
blast differentiation41e44 and the less established but potential role
of WNT5B as a regulator of lineage allocation in osteoblasts45,46,
this expression pattern could also contribute to altered bone
properties in hip OA.
TGFb signalling via SMAD3 has critical effects on the mechanical
and mineral properties of bone; 37,42,47 consistent with this we
found a direct association between SMAD3 expression and the Ca:P
ratio. Also, SMAD3 expression was associated with the composi-
tional changes of Ca:C and P:C in OA cultures, with more profound
differences in the latter differentiation stages, suggesting a direct
role for SMAD3 in the regulation of mineral deposition that is
dysregulated in OA. Further, SMAD3 mRNA expression correlated
with that of OCN and TNAP at late stages exclusively in OA
osteoblasts.
TWIST1, an essential mesenchymal transcription factor whose
down-regulation is required for the progression of osteoblast
differentiation, has also been shown to be differentially expressed
in IT bone of comparable OA cases8,11,13. TWIST1 mRNA expression
changed over time irrespective of group but was signiﬁcantly
higher in OA compared to CTL osteoblasts independently of time.
TWIST1 mRNA expression also correlated positively with both
TNAP and SMAD3 in OA, which was not observed in the CTL cohort.
Both TWIST1 and SMAD3 are critical to osteoblast differentiation
and the process of mineralisation37,38 and an OA-speciﬁc consistent
linear relationship between them in the osteoblast points to
a potentially important role in the progression of OA. In terms of
mineralisation, the association between TWIST1 mRNA expression
and the Ca:C ratio was signiﬁcantly different in OA. Associations
Table V
The comparison of associations from OA and CTL primary osteoblast cultures over
a 42-day time-course between normalised gene expression and mineral measures
using LMEM. The ﬁt of the two LMEMs from OA and CTL for each association was
assessed using a likelihood-ratio test generating an F-value and a subsequent P-
value
Gene Mineral measure Interaction F-value P-value
TNAP Calcium apposition (alizarin red) Group & time 0.88 0.51
Group 0.93 0.34
Time 0.30 0.91
EDS composition (Ca:P) Group & time 1.16 0.35
Group 8.59 0.01
Time 5.84 <0.01
EDS composition (Ca:C) Group & time 0.58 0.72
Group 2.45 0.13
Time 1.36 0.26
EDS composition (P:C) Group & time 0.49 0.78
Group 0.47 0.50
Time 1.05 0.41
OCN Calcium apposition (alizarin red) Group & time 2.20 0.08
Group 0.01 0.92
Time 2.40 0.06
EDS composition (Ca:P) Group & time 2.45 0.06
Group 18.05 <0.01
Time 1.15 0.36
EDS composition (Ca:C) Group & time 0.95 0.46
Group 13.71 <0.01
Time 0.56 0.73
EDS composition (P:C) Group & time 0.34 0.89
Group 0.93 0.34
Time 0.78 0.57
TWIST1 Calcium apposition (alizarin red) Group & time 0.70 0.63
Group 0.01 0.92
Time 1.79 0.14
EDS composition (Ca:P) Group & time 0.77 0.58
Group 3.21 0.08
Time 1.76 0.15
EDS composition (Ca:C) Group & time 0.29 0.91
Group 9.47 <0.01
Time 1.45 0.23
EDS composition (P:C) Group & time 0.18 0.97
Group 1.12 0.30
Time 2.40 0.06
WNT5B Calcium apposition (alizarin red) Group & time 0.72 0.61
Group 1.35 0.25
Time 0.30 0.91
EDS composition (Ca:P) Group & time 1.05 0.41
Group 0.01 0.91
Time 1.61 0.18
EDS composition (Ca:C) Group & time 0.73 0.61
Group 2.29 0.14
Time 0.46 0.80
EDS composition (P:C) Group & time 0.55 0.74
Group 3.62 0.07
Time 1.06 0.40
TGFb1 Calcium apposition (alizarin red) Group & time 0.68 0.64
Group 0.38 0.54
Time 0.44 0.81
EDS composition (Ca:P) Group & time 0.79 0.57
Group 0.10 0.75
Time 0.46 0.80
EDS composition (Ca:C) Group & time 0.22 0.95
Group 0.03 0.86
Time 0.94 0.47
EDS composition (P:C) Group & time 0.49 0.78
Group 0.11 0.75
Time 2.52 0.04
SMAD3 Calcium apposition (alizarin red) Group & time 0.76 0.59
Group 0.03 0.86
Time 0.88 0.51
EDS composition (Ca:P) Group & time 1.50 0.22
Group 0.64 0.43
Time 2.57 0.02
EDS composition (Ca:C) Group & time 3.45 0.01
Table V (continued )
Gene Mineral measure Interaction F-value P-value
Group e e
Time e e
EDS composition (P:C) Group & time 2.81 0.04
Group e e
Time e e
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compared to zero, however the OA association was negative, while
in CTL it was positive. Together, our ﬁndings suggest that TWIST1
contributes to a perturbed osteoblast phenotype in OA and an
intriguing new role for this transcription factor in mineral
deposition.
Previous studies using hip OA osteoblasts utilised between 3
and 14 OA cases from any one gender, and examined the proximal
stages of differentiation (up to 7 days)15e17,40,48e52. In the present
study, ﬁve female OA patients and ﬁve female CTL cases were
examined over a 42-day time-course. This sample number is one of
the study limitations since some of the measures approached but
did not achieve signiﬁcance. However, the gene-cohort, geneegene,
gene-mineral and mineralecohort relationships identiﬁed here
serve as a rational basis for future studies using larger cohort sizes
and or studies focussing on the downstream functions of these
genes. The number of measures and time points examined neces-
sitated expansion of cultures up to passage 4. While use of this
passage is another perceived study limitation, the phenotype of
human bone explant-derived cells is relatively stable (see
Methods). The altered characteristics of OA osteoblasts identiﬁed
here can be taken to be intrinsic since they persisted ex vivo for
several weeks prior to experimentation. This study is also one of the
very few to examine OA osteoblasts from the IT region, distal from
the subchondral inﬂammatory milieu52.
In conclusion, this study suggests that intrinsic osteoblast
behaviour is altered in OA. We have shown that several genesTable VI
Speciﬁc assessment against zero (no association at all) of associations between
normalised gene expression andmineralmeasures assessing calcium apposition and
composition in OA and non-OA CTL primary osteoblast cultures over a 42-day time-
course*
Association Group Regression coefﬁcient t-value P-value
TNAP and Ca:P CTL þ8022.88 þ2.35 0.02
OCN and Ca:P OA 4957.41 4.29 <0.01
OCN and Ca:C OA 7489.35 4.10 <0.01
TWIST1 and Ca:C OA 42.20 3.97 <0.01
TWIST1 and Ca:C CTL þ156.46 þ2.44 0.02
* Only associations with signiﬁcant differences are presented.
Table VII
Speciﬁc analysis of temporal differences against zero (no association at all) within
associations between normalised gene expression and mineral measures assessing
calcium apposition and composition in OA and non-OA CTL primary osteoblast
cultures over a 42-day time-course*
Association Time (days) Regression coefﬁcient t-value P-value
TNAP and Ca:P 42 27872.00 3.55 <0.01
TGFb1 and P:C 14 3.57 2.24 0.03
SMAD3 and Ca:P 42 94.97 2.64 0.01
SMAD3 and Ca:C (OA) 7 182.63 2.16 0.04
28 246.47 2.67 0.01
35 144.90 2.60 0.01
42 266.13 2.74 0.01
SMAD3 and Ca:C (CTL) 42 288.12 2.56 0.02
SMAD3 and P:C (OA) 35 85.29 2.38 0.02
* Only associations with signiﬁcant differences are presented.
D.D. Kumarasinghe et al. / Osteoarthritis and Cartilage 20 (2012) 1357e1366 1365previously identiﬁed in primary hip OA bone as dysregulated, in
particular TGFb1, SMAD3, and TWIST1, are associated with these
altered properties. Further studies of gene regulation and miner-
alisation in OA osteoblasts are warranted to fully characterise the
bony component of OA.
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